Literature DB >> 10737022

[Effects of healthy aging on the regional cerebral blood flow measurements using 99mTc-ECD SPECT assessed with statistical parametric mapping].

S Nakano1, T Asada, H Matsuda, M Uno, M Takasaki.   

Abstract

To clarify the effects of normal aging on the cerebral blood flow, regional cerebral blood flow measurements++ using a Patlak Plot method of 99mTc-ECD were performed in 53 normal volunteers aged 18 to 87 years old (mean = 47.9 years). The subjects, 29 men and 24 women, were normal on clinical examination, and had neither a history of neurological nor psychiatric disease and no abnormal CT or MRI images. Statistical parametric mapping (SPM) was used for automatching and an objective approach to analysis of SPECT image data. Global cerebral blood flow showed a significant decline with age (r = 0.406). The SPM analysis (voxel height; p < 0.001, Bonferroni correction; p < 0.05) demonstrated significant age-related decrease of relative rCBF in prefrontal cortices, anterior cingulate giri, and insular cortices-temporal poles bilaterally, these affected areas belonged to limbic or association cortices. Therefore, these decreases in rCBF may suggest cognitive changes that occur during normal aging.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737022     DOI: 10.3143/geriatrics.37.49

Source DB:  PubMed          Journal:  Nihon Ronen Igakkai Zasshi        ISSN: 0300-9173


  2 in total

1.  Effects of aging on regional cerebral blood flow assessed by using technetium Tc 99m hexamethylpropyleneamine oxime single-photon emission tomography with 3D stereotactic surface projection analysis.

Authors:  Kazuo Takahashi; Shuhei Yamaguchi; Shotai Kobayashi; Yasushi Yamamoto
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  Insulin-like growth factor-1 in CNS and cerebrovascular aging.

Authors:  William E Sonntag; Ferenc Deak; Nicole Ashpole; Peter Toth; Anna Csiszar; Willard Freeman; Zoltan Ungvari
Journal:  Front Aging Neurosci       Date:  2013-07-02       Impact factor: 5.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.